Amphix Bio

Amphix Bio was spun out from Northwestern University in Chicago, Illinois in 2021. The company is developing a novel platform technology—Supramolecular Therapeutic Peptides (STPs)—which can modulate immune responses and initiate regenerative processes to restore functions lost due to injury, disease, or aging. These therapies work by triggering targeted signaling pathways while forming scaffolds that support biological repair. Amphix Bio's goal is to extend the human healthspan—the length of time people can live productively and fulfilling lives.